Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02146157 · ClinicalTrials.gov registry record · NA
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A NA study of PreDiabetes, sponsored by NewChapter.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 6
- Study locations
NCT02146157: Completed NA study of PreDiabetes, sponsored by NewChapter.
NCT02146157 is a NA study of PreDiabetes that has completed, run by NewChapter. The registered enrollment target is 104 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (85% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02146157, a NA study of PreDiabetes, has completed, sponsored by NewChapter.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a multi-center, randomized, double-blind, placebo-controlled study in approximately 104 subjects (52 per group) to evaluate the effectiveness of an herb and mineral combination product on fasting serum glucose levels in subjects with impaired fasting glucose. The study consists of 5 visits: a Screening visit, followed by a Baseline visit (at which eligible subjects will be randomized to product to consume throughout the 12-week supplementation period), followed by Supplementation period visits at 3, 6 and 12 weeks after baseline.
Primary Outcome
Fasting glucose will be measured on serum samples obtained at screening (to be used as baseline value) and at day 84
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT herb and mineral combination product
Study Locations (6)
Ohio
- Radiant Research - Cincinnati
- Providence Health Partners Center for Clinical Research - Dayton
Illinois
- Radiant Research - Chicago
Kentucky
- Central Kentucky Research Associates - Lexington
Michigan
- Quest Research Institute - Bingham Farms
South Carolina
- Mountain View Clinical Research - Greer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT02146157 record still lists
NCT02146157 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (85% lower).
The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02146157 lists 6 locations in 5 states (Ohio, Illinois, Kentucky).
Frequently Asked Questions
What is clinical trial NCT02146157 about?
NCT02146157 is a clinical study titled "Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes". This is a multi-center, randomized, double-blind, placebo-controlled study in approximately 104 subjects (52 per group) to evaluate the effectiveness of an herb and mineral combination product on fasting serum glucose levels in subjects with impaired fasting glucose. The study consists of 5 visits: ...
What is the current status of trial NCT02146157?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2013-02. Estimated completion is 2015-06.
What conditions does trial NCT02146157 study?
This clinical trial studies the following conditions: PreDiabetes.
What interventions are being tested in trial NCT02146157?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), herb and mineral combination product (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02146157?
This trial is sponsored by NewChapter, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02146157 being conducted?
This trial has 6 study locations across Illinois, Kentucky, Michigan, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02146157's enrollment target sits among peer trials
104 57th of 149 higher than 93 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia